- Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
- Zai Lab Announces Participation in November Investor Conferences
- Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023
- Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China
- Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China
- Zai Lab Announces Participation in September Investor Conferences
- Zai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
More ▼
Key statistics
On Thursday, Zai Lab Ltd (ZLAB:NMQ) closed at 18.87, 39.99% above the 52 week low of 13.48 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.94 |
---|---|
High | 19.23 |
Low | 18.63 |
Bid | 16.60 |
Offer | 21.75 |
Previous close | 18.87 |
Average volume | 646.89k |
---|---|
Shares outstanding | 99.61m |
Free float | 97.44m |
P/E (TTM) | -- |
Market cap | 1.85bn USD |
EPS (TTM) | -3.50 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 21:00 BST.
More ▼